BFC Planning’s Lexicon Pharmaceuticals LXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-1,000
Closed -$2.4K – 3553
2026
Q2
$2.4K Buy
+1,000
New +$1.95K ﹤0.01% 2943

Other funds holding LXRX

BFC Planning's LXRX Position: Q3 2026 in Review

BFC Planning sold out of Lexicon Pharmaceuticals (LXRX) in Q3 2026, closing a stake of 1,000 shares — an estimated $2.4K sold.

BFC Planning first reported a position in LXRX in Q2 2026 and held it in 1 quarter. The position peaked at $2.4K in Q2 2026. 112 funds tracked by Wall St. Rank hold LXRX as of Q3 2026.

  • BFC Planning reported no remaining Lexicon Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
  • BFC Planning sold 1,000 Lexicon Pharmaceuticals shares in Q3 2026, an estimated $2.4K.
  • BFC Planning first reported a position in Lexicon Pharmaceuticals in Q2 2026 and held it in 1 quarter.
  • BFC Planning's Lexicon Pharmaceuticals position peaked at $2.4K in Q2 2026.
  • 112 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q3 2026.

Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.